Thiopurine S-methyltransferase (TPMT) is a cytosolic enzyme which catalyses the S-methylation of thiopurine drugs. TMPT converts 6-MP to metabolites other than the thioguanine nucleotides thought to be responsible for their main cytotoxic action. Haematological side effects of thiopurines are influenced by TPMT deficiency (myelosuppression). A standard dose of thiopurine drugs in homozygous mutant individuals is likely to cause pancytopaenia and sometimes death and there is a growing body of evidence suggesting heterozygotes are also at higher risk of haematological complications (note that normal individuals still have a background risk of developing haematological complications).
Genetics - Molecular Pathology
TPMT
Send samples for either TPMT or TPMT genotyping to Specialist Biochemistry
Specialist Biochemistry - fridge
Do not freeze or separate samples
TPMT
Thiopurine methyltransferase genotyping
4 weeks
7302